FDA grants fast track designation for SPI-1005 in the treatment of Meniere's disease

18 September 2019 - Sound Pharmaceuticals is pleased to announce that the FDA's Division of Neurology Products has granted its request ...

Read more →

Wave Life Sciences announces fast track designation from U.S. FDA for suvodirsen

16 September 2019 - Suvodirsen is an investigational stereopure oligonucleotide in development for the treatment of DMD patients amenable to exon ...

Read more →

FDA grants fast track designation for Farxiga in heart failure

16 September 2019 - AstraZeneca today announced that the US FDA has granted fast track designation for the development of ...

Read more →

ProQR receives fast track designation from FDA for QR-1123 for autosomal dominant retinitis pigmentosa

9 September 2019 - ProQR Therapeutics today announced that it received fast track designation from the FDA for QR-1123. ...

Read more →

FDA grants fast track status to Amplyx Pharmaceuticals for IV and oral formulations of fosmanogepix (APX001) for seven different indications

9 September 2019 -  -- Amplyx Pharmaceuticals announced today that the U.S. FDA has granted fast track designations for both ...

Read more →

FDA grants AMG 510 fast track designation for previously treated metastatic NSCLC with KRAS G12C mutation

8 September 2019 - Amgen today announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with ...

Read more →

Forty Seven granted fast track designation for magrolimab for the treatment of myelodysplastic syndrome and acute myeloid leukaemia

3 September 2019 - Forty Seven today announced that the U.S. FDA has granted fast track designation to magrolimab (formerly known ...

Read more →

Inotrem announces fast track designation granted by U.S. FDA to nangibotide development program for the treatment of septic shock

4 September 2019 - Inotrem announced today that the U.S. FDA has granted fast track designation to nangibotide development program for ...

Read more →

Zensun announces the investigation of Neucardin for chronic heart failure receives fast track designation from the US FDA

26 August 2019 - Zensun announced that the investigation of Neucardin, its recombinant human neuregulin-1 fragment, has received fast track designation ...

Read more →

Emalex Biosciences receives FDA fast track designation for ecopipam for the treatment of patients with Tourette syndrome

28 August 2019 - Emalex Biosciences announced today that it has received fast track designation for its investigational product, ecopipam, from ...

Read more →

DiscGenics receives FDA fast track designation for disc degeneration cell therapy

26 August 2019 - DiscGenics today announced that the U.S. FDA has granted Fast Track designation for its investigational cell ...

Read more →

FDA grants fast track designation for Farxiga in chronic kidney disease

27 August 2019 - AstraZeneca today announced that the US FDA has granted fast track designation for the development of ...

Read more →

Medipost’s Pneumostem gets FDA’s fast-track designation

23 August 2019 - Medipost said that the U.S. FDA has given a fast- track designation for Pneumostem, a bronchopulmonary ...

Read more →

Cerecor receives fast track designation from FDA for CERC-802 for the treatment of mannose-phosphate isomerase deficiency

21 August 2019 - Cerecor announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...

Read more →

Moderna receives FDA fast track designation for Zika vaccine mRNA-1893

19 August 2019 - Moderna today announced that the U.S. FDA has granted fast track designation for its investigational Zika vaccine ...

Read more →